NCT05203172 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05203172
Title	The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
Recruitment	Recruiting
Gender	both
Phase	FDA approved
Variant Requirements	Yes
Sponsors	Pfizer
Indications	Advanced Solid Tumor skin melanoma colorectal cancer melanoma
Therapies	Encorafenib Binimetinib + Encorafenib Binimetinib + Encorafenib + Ribociclib Binimetinib + Cetuximab + Encorafenib Binimetinib
Age Groups:	adult \| senior
Covered Countries	USA \| SVK \| NLD \| ITA \| ISR \| HUN \| GBR \| FRA \| ESP \| DEU \| CZE \| CAN \| BRA \| AUS

NCT05203172
Clinical Trial Detail